-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Dear exhibitors, visitors and industry colleagues: The 87th China International Pharmaceutical API/Intermediate/Packaging/Equipment Fair (API China) and the 25th China International Pharmaceutical (Industry) Exhibition and Technology Exchange Conference (CHINA-PHARM) will be held on October 12-14 at Wuhan International Expo Center as scheduled
.
2021 is the first year of the "14th Five-Year Plan", and it is also a critical period for the transformation of China's pharmaceutical industry
.
With the in-depth development of the quality and efficacy consistency evaluation of generic drugs, and the continuous implementation of a number of medical reform measures such as normalization and refinement of bulk purchases, China's pharmaceutical industry is undergoing an in-depth change
.
On the policy side, pharmaceutical companies need to pay close attention to changes in the Pharmacopoeia, ICH, and PIC/s, and continue to pay attention to the resulting impact; on the production side, pharmaceutical companies need to optimize the supply chain and improve the continuous, digital, intelligent and efficient pharmaceutical process.
The level of intensification ensures the stable supply of drugs; on the supply side, with the advancement of the review and approval of the original auxiliary packaging and pharmaceutical preparations, pharmaceutical companies and original auxiliary packaging suppliers need to maintain continuous and efficient communication, and carry out product associations and changes to ensure supply.
Stable; on the product side, preparation companies need to pay attention to the research and development of innovative drugs, especially biological preparations, improved new drugs and complex preparations, and enrich their product lines through joint development or outsourcing
.
The 87th API China API and the 25th CHINA-PHARM Pharmaceutical Industry Exhibition are held at this time.
They will focus on the current hot issues and general trends of the industry, and create valuable face-to-face communication, cooperation and sharing for all colleagues in the Chinese pharmaceutical industry.
Win the opportunity to share the world of unlimited business opportunities! The 87th API China and the 25th CHINA-PHARM were held concurrently with the China Food and Drug International Exchange Center, the Food and Drug Inspection Center of the State Drug Administration, the State Pharmacopoeia Commission, the China Chemical and Pharmaceutical Industry Association, the China Pharmaceutical Packaging Association, the International Pharmaceutical Engineering Association, China Biochemical Pharmaceutical Industry Association, International Pharmaceutical Excipients Association (China) and other units will hold more than 30 special forums from the aspects of policies, regulations, supervision, markets, products and technologies
.
The content covers international regulations of the pharmaceutical industry, "Chinese Pharmacopoeia", antibody drug supervision, PIC/s, ICH Q8-Q12, ICH Q13, green pharmaceuticals, micro-reaction continuous production, environmental protection and three-waste management, intelligent manufacturing and intelligent factories, pharmaceutical raw materials and Disposable systems, industrial practices and challenges for biological products, CXO research and development, complex formulation development, pharmaceutical industry informatization and automation,
etc.
At that time, more than 100 industry experts, more than 1,000 original and auxiliary packaging and equipment companies, and tens of thousands of industry elites will gather in the heroic Wuhan to jointly build an exchange, cooperation and display platform covering the entire life cycle of drug R&D and production and the entire industry chain.
Showcasing new products, technologies and full-process solutions for drug production and research and development, and disseminating advanced pharmaceutical concepts
.
The Organizing Committee of API China and CHINA-PHARM will work closely with the Wuhan Municipal Government, Wuhan International Expo Center and other units to ensure the health and safety of the visitors
.
We will go all out to do business opportunities, exhibitor services, visitor invitations, etc.
, and join hands with all colleagues in China's pharmaceutical industry to link the entire pharmaceutical industry chain, stimulate industry innovation and vitality, and jointly build a large platform for China's pharmaceutical internal circulation and the global pharmaceutical industry.
Origin of the chain
.
Thank you for your support to API China API China and CHINA-PHARM Pharmaceutical Industry Exhibition for decades.
See you in Wuhan on October 12th! Click to pre-register
.
2021 is the first year of the "14th Five-Year Plan", and it is also a critical period for the transformation of China's pharmaceutical industry
.
With the in-depth development of the quality and efficacy consistency evaluation of generic drugs, and the continuous implementation of a number of medical reform measures such as normalization and refinement of bulk purchases, China's pharmaceutical industry is undergoing an in-depth change
.
On the policy side, pharmaceutical companies need to pay close attention to changes in the Pharmacopoeia, ICH, and PIC/s, and continue to pay attention to the resulting impact; on the production side, pharmaceutical companies need to optimize the supply chain and improve the continuous, digital, intelligent and efficient pharmaceutical process.
The level of intensification ensures the stable supply of drugs; on the supply side, with the advancement of the review and approval of the original auxiliary packaging and pharmaceutical preparations, pharmaceutical companies and original auxiliary packaging suppliers need to maintain continuous and efficient communication, and carry out product associations and changes to ensure supply.
Stable; on the product side, preparation companies need to pay attention to the research and development of innovative drugs, especially biological preparations, improved new drugs and complex preparations, and enrich their product lines through joint development or outsourcing
.
The 87th API China API and the 25th CHINA-PHARM Pharmaceutical Industry Exhibition are held at this time.
They will focus on the current hot issues and general trends of the industry, and create valuable face-to-face communication, cooperation and sharing for all colleagues in the Chinese pharmaceutical industry.
Win the opportunity to share the world of unlimited business opportunities! The 87th API China and the 25th CHINA-PHARM were held concurrently with the China Food and Drug International Exchange Center, the Food and Drug Inspection Center of the State Drug Administration, the State Pharmacopoeia Commission, the China Chemical and Pharmaceutical Industry Association, the China Pharmaceutical Packaging Association, the International Pharmaceutical Engineering Association, China Biochemical Pharmaceutical Industry Association, International Pharmaceutical Excipients Association (China) and other units will hold more than 30 special forums from the aspects of policies, regulations, supervision, markets, products and technologies
.
The content covers international regulations of the pharmaceutical industry, "Chinese Pharmacopoeia", antibody drug supervision, PIC/s, ICH Q8-Q12, ICH Q13, green pharmaceuticals, micro-reaction continuous production, environmental protection and three-waste management, intelligent manufacturing and intelligent factories, pharmaceutical raw materials and Disposable systems, industrial practices and challenges for biological products, CXO research and development, complex formulation development, pharmaceutical industry informatization and automation,
etc.
At that time, more than 100 industry experts, more than 1,000 original and auxiliary packaging and equipment companies, and tens of thousands of industry elites will gather in the heroic Wuhan to jointly build an exchange, cooperation and display platform covering the entire life cycle of drug R&D and production and the entire industry chain.
Showcasing new products, technologies and full-process solutions for drug production and research and development, and disseminating advanced pharmaceutical concepts
.
The Organizing Committee of API China and CHINA-PHARM will work closely with the Wuhan Municipal Government, Wuhan International Expo Center and other units to ensure the health and safety of the visitors
.
We will go all out to do business opportunities, exhibitor services, visitor invitations, etc.
, and join hands with all colleagues in China's pharmaceutical industry to link the entire pharmaceutical industry chain, stimulate industry innovation and vitality, and jointly build a large platform for China's pharmaceutical internal circulation and the global pharmaceutical industry.
Origin of the chain
.
Thank you for your support to API China API China and CHINA-PHARM Pharmaceutical Industry Exhibition for decades.
See you in Wuhan on October 12th! Click to pre-register
